ARMP - AMEX

Armata Pharmaceuticals, Inc.

ARMP·AMEX

$7.69

-2.9%

HealthcareBiotechnology

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$282.31M

EPS-4.8000

P/E Ratio-1.60

Earnings Date08/11/2026

armp

Short Term Debt

Last Annual Value

4.56M

3-Year CAGR

-36%

5-Year CAGR

45%

10-Year CAGR

Adjust for Inflation

Armata Pharmaceuticals, Inc. Competitors Analysis of Short Term Debt

ARMP · AMEX

Company	Short Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
Armata Pharmaceuticals, Inc. AMEX:ARMP	4.56M	N/A	N/A	19.0%
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	544.00K	N/A	22.4%	-10.8%
Nuvectis Pharma, Inc. NASDAQ:NVCT	0.00	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. NASDAQ:NTHI	5.95M	-3.4%	39.0%	N/A
Codexis, Inc. NASDAQ:CDXS	0.00	N/A	N/A	N/A
C4 Therapeutics, Inc. NASDAQ:CCCC	6.37M	N/A	N/A	N/A
Insight Molecular Diagnostics Inc. NASDAQ:IMDX	1.81M	N/A	6.6%	24.5%
Sangamo Therapeutics, Inc. NASDAQ:SGMO	0.00	N/A	N/A	N/A
OmniAb, Inc. NASDAQ:OABI	3.88M	N/A	N/A	N/A

Armata Pharmaceuticals, Inc. Fair Value Envelope

ARMP · AMEX

Our analysis suggests that ARMP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $7.69, this represents a potential HIDDEN relative to our calculated worth for Armata Pharmaceuticals, Inc..

HIDDEN

Intrinsic Value

Current Price: $7.69

Related Guides

Blog Categories

Continue your ARMP research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.